Hologic (HOLX)
NASDAQ:HOLX

Hologic (HOLX) Stock Price & Analysis

870 Followers

HOLX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$59.78 - $87.88
Previous Close$79.03
Volume1.10M
Average Volume (3M)1.34M
Market Cap
$19.45B
Enterprise Value$19.71B
Total Cash (Recent Filing)$2.58B
Total Debt (Recent Filing)$2.84B
Price to Earnings (P/E)26.4
Beta0.57
Jul 26, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.00
Shares Outstanding246,118,192
10 Day Avg. Volume1,323,135
30 Day Avg. Volume1,342,596
Standard Deviation0.10
R-Squared0.32
Alpha0.00860
Financial Highlights & Ratios
Price to Book (P/B)-23.86
Price to Sales (P/S)19.96
Price to Cash Flow (P/CF)22.40
P/FCF Ratio20.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.99
Enterprise Value/Gross Profit6.58
Enterprise Value/Ebitda21.04
Forecast
Price Target Upside17.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

HOLX FAQ

What was Hologic’s price range in the past 12 months?
Hologic lowest stock price was $59.78 and its highest was $87.88 in the past 12 months.
    What is Hologic’s market cap?
    Currently, no data Available
    When is Hologic’s upcoming earnings report date?
    Hologic’s upcoming earnings report date is Jul 26, 2023 which is in 59 days.
      How were Hologic’s earnings last quarter?
      Hologic released its earnings results on May 01, 2023. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.877 by $0.183.
        Is Hologic overvalued?
        According to Wall Street analysts Hologic’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Hologic pay dividends?
          Hologic does not currently pay dividends.
          What is Hologic’s EPS estimate?
          Hologic’s EPS estimate is $0.89.
            How many shares outstanding does Hologic have?
            Hologic has 246,118,200 shares outstanding.
              What happened to Hologic’s price movement after its last earnings report?
              Hologic reported an EPS of $1.06 in its last earnings report, beating expectations of $0.877. Following the earnings report the stock price went down -4.22%.
                Which hedge fund is a major shareholder of Hologic?
                Among the largest hedge funds holding Hologic’s share is Bridgewater Associates, LP. It holds Hologic’s shares valued at 44M.

                  ---

                  Hologic Stock Smart Score

                  The Hologic stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Hologic

                  Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.

                  ---

                  Top 5 ETFs holding HOLX

                  Name
                  Market Value
                  Smart Score
                  Vanguard S&P 500 ETF
                  $464.29M
                  8
                  SPDR S&P 500 ETF Trust
                  $219.85M
                  8
                  SPDR S&P 500 ETF Trust CDI
                  $217.15M
                  8
                  iShares Core S&P 500 ETF
                  $171.37M
                  8
                  First Trust Capital Strength ETF
                  $162.61M
                  8
                  Up to five ETFs with an Outperform Smart Score that hold HOLX. The ETFs are listed according to market value of HOLX within the ETF

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Idexx Laboratories
                  Resmed
                  Baxter International
                  Zimmer Biomet Holdings
                  Insulet

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis